Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Shire plc | dp16296_8k.htm |
EXHIBIT 99.1
|
Press Release
www.shire.com
|
 |
Notification
of major interests in shares
January 26,
2010 - Shire plc (LSE: SHP, NASDAQ: SHPGY)
1.
Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached:
Shire
plc
|
2. Reason for
the notification
|
State
Yes/No
|
|
An
acquisition or disposal of voting rights
|
Yes
|
|
An
acquisition or disposal of qualifying financial instruments which may
result in the acquisition of shares already issued to which voting rights
are attached
|
No
|
|
An
acquisition or disposal of instruments with similar economic effect to
qualifying financial instruments
|
No
|
|
An event
changing the breakdown of voting rights
|
No
|
|
Other (please
specify):
|
No
|
|
3. Full name
of person(s) subject to the notification obligation:
|
Invesco
Limited
|
|
4. Full name
of shareholder(s) (if different from 3.):
|
N/A
|
|
5. Date of
the transaction (and date on which the threshold is crossed
or reached if
different):
|
21 January
2010
|
|
6. Date on
which issuer notified:
|
22 January
2010
|
|
7.
Threshold(s) that is/are crossed or reached:
|
Below
3%
|
|
8. Notified
details:
|
A:
Voting rights attached to shares
|
Class/type of
shares
if
possible using the ISIN CODE
|
Situation
previous to
the
Triggering
transaction
|
Resulting
situation after the triggering
transaction
|
|||||
|
Number
of
Shares
|
Number
of
Voting
Rights
|
Number
of
shares
|
Number of
voting
rights
|
% of
voting
rights
|
|||
|
Direct
|
Indirect
|
Direct
|
Indirect
|
||||
|
Ord 5p Shares
and ADR’s 3:1
JE00B2QKY057
|
17,479,662
|
17,479,662
|
N/A
|
N/A
|
16,095,485
|
N/A
|
2.86%
|
B:
Qualifying Financial Instruments
Resulting situation
after the triggering transaction
|
Type of
financial
instrument
|
Expiration
date
|
Exercise/Conversion
Period/
Date
|
Number of
voting
rights that
may be
acquired
if the instrument
is
exercised/converted
|
% of
voting
rights
|
|
C: Financial
Instruments with similar economic effect to Qualifying Financial
Instruments
|
|
Resulting
situation after the triggering transaction
|
|
Type of
financial
instrument
|
Exercise
price
|
Expiration
date
|
Exercise/
Conversion
period
|
Number of
voting
rights
instrument
refers
to
|
% of voting
rights
|
|
|
Nominal
|
Delta
|
|||||
|
Total
(A+B+C)
|
|
|
Number of
voting rights
|
% of voting
rights
|
|
16,095,485
|
2.86
|
9.
Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
|
Invesco
Trimark Ltd & AiM Advisors – 2,004,101
AiM Advisors
Inc. – 9,269,548
AiM Capital
Management Inc. – 1,218,698
Invesco
Trimark Limited (Canada) – 131,000
Invesco
Taiwan Limited – 6,400
Invesco Asset
Management Limited – 10,959
Invesco GT
Management S.A Lux & AiM Capital Management Inc. –
129,682
Invesco
PowerShares Capital Management Ireland – 315
Invesco
PowerShares Capital Management LLC – 2,564
ADR’s
3,322,218
|
|
Proxy
Voting:
10. Name of
the proxy holder:
|
N/A
|
|
11. Number of
voting rights proxy holder will cease to hold:
|
N/A
|
|
12. Date on
which proxy holder will cease to hold voting rights:
|
N/A
|
|
13.
Additional information:
|
|
|
14. Contact
name:
|
Samantha
Edwards
|
|
15. Contact
telephone number:
|
01491
416381
|
Contact at Shire
plc: Tony Guthrie, Deputy Company Secretary, 01256 894746
For
further information please contact:
|
Investor
Relations
|
Cléa
Rosenfeld (Rest of the World)
|
+44 1256 894
160
|
|
|
Eric Rojas
(North America)
|
+1 617 551
9715
|
Notes
to editors
SHIRE
PLC
Shire’s strategic
goal is to become the leading specialty biopharmaceutical company that focuses
on meeting the needs of the specialist physician. Shire focuses its
business on attention deficit hyperactivity disorder (ADHD), human genetic
therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in
other therapeutic areas to the extent they arise through
acquisitions. Shire’s in-licensing, merger and acquisition efforts
are focused on products in specialist markets with strong intellectual property
protection and global rights. Shire believes that a carefully
selected and balanced portfolio of products with strategically aligned and
relatively small-scale sales forces will deliver strong results.
For further
information on Shire, please visit the Company’s website: www.shire.com.